The Tengku Ampuan Rahimah Hospital in Klang, also known as Klang General Hospital or Klang GH is a 1094-bed government tertiary hospital located in the south of the royal town of Klang, Selangor, Malaysia.

There are 1,094 beds in Hospital Tengku Ampuan Rahimah.

During the past decade, Hospital Tengku Ampuan Rahimah conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Tengku Ampuan Rahimah" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Ministry of Health, Malaysia" with 2 trials sponsored, "University of Malaya" with 2 trials sponsored, "Ark Biosciences Inc." with 1 trials sponsored and "Baxalta now part of Shire" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Tengku Ampuan Rahimah" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Ark Biosciences Pty Ltd." with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Ministry of Health, Malaysia" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Tengku Ampuan Rahimah" are "Lupus Nephritis" (2 trials), "Anaesthesia" (1 trials), "Cancer" (1 trials), "Chronic Renal Failure Related Anemia" (1 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Hospital Tengku Ampuan Rahimah" in a lesser frequency.

Most popular intervention types in "Hospital Tengku Ampuan Rahimah" are "Drug" (8 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "AK0529" (1 trials), "Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method" (1 trials), "BI 655064" (1 trials) and "BI 655064 dose 1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Tengku Ampuan Rahimah" are 10 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Tengku Ampuan Rahimah". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Hospital Tengku Ampuan Rahimah, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Tengku Ampuan Rahimah, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".